Literature DB >> 11373520

Diagnosis of intra-abdominal infection in the critically ill patient.

H L Evans1, D P Raymond, S J Pelletier, T D Crabtree, T L Pruett, R G Sawyer.   

Abstract

Intra-abdominal infection continues to pose a significant threat to critically ill patients in the year 2000. A review of the current literature reveals that despite remarkable developments in critical care medicine and extensive study of patients with tertiary peritonitis, the associated mortality rate remains nearly 30%. Progress has been limited by the difficulty of comparing heterogeneous patient populations, groups that manifest a host of comorbid, potentially confounding illnesses. Additionally, debate persists regarding the definitions of secondary and tertiary peritonitis, resulting in varied study inclusion criteria, and further complicating data analysis and interpretation. Scoring systems developed to identify those patients at risk for progression to tertiary peritonitis, the more chronic, lethal form of intra-abdominal infection associated with multisystem organ failure, reflect the current emphasis in the literature on the importance of early diagnosis and early intervention. This has led to a renewed interest in conservative, data-dependent surgical management employing radiographic and microbiologic evidence to guide therapy.

Entities:  

Mesh:

Year:  2001        PMID: 11373520     DOI: 10.1097/00075198-200104000-00010

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  17 in total

1.  Increased Resistin Levels in Intra-abdominal Sepsis: Correlation with proinflammatory cytokines and Acute Physiology and Chronic Health Evaluation (APACHE) II scores.

Authors:  Tonguç U Yilmaz; Mustafa Kerem; Canan Y Demirtaş; Ozge Pasaoǧlu; Oge Taşcilar; Omer Sakrak; Kürşat Dikmen; Tarkan Karahan
Journal:  Sultan Qaboos Univ Med J       Date:  2014-10-14

Review 2.  The challenge of post-operative peritonitis after gastrointestinal surgery.

Authors:  Massimo Sartelli; Ewen A Griffiths; Maurizio Nestori
Journal:  Updates Surg       Date:  2015-08-12

3.  Liver injury and abscess formation in secondary murine peritonitis.

Authors:  Andreas M Lenz; Mark Fairweather; James C Peyton; Sarah A Gardner; William G Cheadle
Journal:  Inflamm Res       Date:  2010-10-26       Impact factor: 4.575

4.  Infectiological diagnostic problems in tertiary peritonitis.

Authors:  G Weiss; F Meyer; H Lippert
Journal:  Langenbecks Arch Surg       Date:  2006-08-15       Impact factor: 3.445

Review 5.  Critical issues in the clinical management of complicated intra-abdominal infections.

Authors:  Stijn Blot; Jan J De Waele
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Age, microbiology and prognostic scores help to differentiate between secondary and tertiary peritonitis.

Authors:  Peter Panhofer; Barbara Izay; Markus Riedl; Veronika Ferenc; Martin Ploder; Raimund Jakesz; Peter Götzinger
Journal:  Langenbecks Arch Surg       Date:  2008-03-15       Impact factor: 3.445

7.  Identification of patients at risk for development of tertiary peritonitis on a surgical intensive care unit.

Authors:  Ansgar M Chromik; Andreas Meiser; Janine Hölling; Dominique Sülberg; Adrien Daigeler; Kirsten Meurer; Heike Vogelsang; Matthias H Seelig; Waldemar Uhl
Journal:  J Gastrointest Surg       Date:  2009-04-08       Impact factor: 3.452

8.  Procalcitonin ratio and on-demand relaparotomy for septic peritonitis: validation of the focus index (FI).

Authors:  Volker Assfalg; Petra Wolf; Daniel Reim; Norbert Hüser; Georg Hellbrügge; Edouard Matevossian; Helmut Friess; Bernhard Holzmann; Klaus L Emmanuel; Alexander R Novotny
Journal:  Surg Today       Date:  2015-07-27       Impact factor: 2.549

9.  Essentials for selecting antimicrobial therapy for intra-abdominal infections.

Authors:  Stijn Blot; Jan J De Waele; Dirk Vogelaers
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

Review 10.  Treatment of complicated intra-abdominal infections in the era of multi-drug resistant bacteria.

Authors:  T Herzog; A M Chromik; Waldemar Uhl
Journal:  Eur J Med Res       Date:  2010-11-30       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.